Laman UtamaCORT • NASDAQ
add
Corcept Therapeutics Inc
$64.60
Selepas Waktu Dagangan:(0.00%)0.00
$64.60
Tutup: 16 Apr, 4:35:27 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$69.59
Julat hari
$63.75 - $70.20
Julat tahun
$20.84 - $117.33
Permodalan pasaran
6.82B USD
Bilangan Purata
1.98J
Nisbah P/E
51.91
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 181.89J | 34.33% |
Perbelanjaan pengendalian | 153.67J | 50.87% |
Pendapatan bersih | 30.75J | -1.94% |
Margin untung bersih | 16.90 | -27.03% |
Pendapatan bagi setiap syer | 0.26 | -7.14% |
EBITDA | 25.54J | -19.89% |
Kadar cukai berkesan | 3.80% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 383.33J | 4.10% |
Jumlah aset | 840.55J | 35.24% |
Jumlah liabiliti | 160.96J | 40.20% |
Jumlah ekuiti | 679.59J | — |
Syer tertunggak | 105.50J | — |
Harga kepada buku | 10.76 | — |
Pulangan pada aset | 7.77% | — |
Pulangan pada modal | 9.48% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 30.75J | -1.94% |
Tunai daripada operasi | 59.30J | 907.30% |
Tunai daripada pelaburan | -64.36J | -476.42% |
Tunai daripada pembiayaan | -4.56J | -695.82% |
Perubahan bersih dalam tunai | -9.62J | -140.52% |
Aliran tunai bebas | 45.46J | 2,538.10% |
Perihal
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
Diasaskan
13 Mei 1998
Ibu pejabat
Tapak web
Pekerja
500
